Bisoprolol, but not verapamil, eases peak oxygen consumption in nonobstructive HCM
Peak oxygen consumption (pVO2) in patients with nonobstructive hypertrophic cardiomyopathy (HCM) is reduced following treatment with the beta-blocker bisoprolol but remains unchanged with the calcium-channel blocker verapamil, reports a study.
Bisoprolol, but not verapamil, eases peak oxygen consumption in nonobstructive HCM
13 Mar 2026